Related Experiment Video
Updated: Feb 6, 2026

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling
Published on: July 4, 2007
Strategies for Predicting Response to Checkpoint Inhibitors
Roberta Zappasodi1,2, Jedd D Wolchok1,2,3,4, Taha Merghoub5,6,7
1Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Purpose Of Review:
Despite the clinical successes of immune checkpoint blockade across multiple tumor types, many patients do not respond to these therapies or become resistant after an initial response. This underscores the need to improve our understanding of the molecular determinants of response to guide more personalized and rational utilization of these therapies. Here, we describe available biomarkers of checkpoint blockade activity by classifying them into four major categories: tumor-intrinsic, immune microenvironmental, host-related, and dynamic factors.
Recent Findings:
The clinical experience accumulated thus far with checkpoint blockade now offers the opportunity to comprehensively study the molecular and immune features associated with response. This is yielding a growing set of biomarkers whose integration will be key to more accurately predict clinical outcome. We propose a model for systematic assessment of available baseline and dynamic biomarkers in relationship with patients' outcomes. This will improve our understanding of the tumor-immune interactions and dynamics that predict a clinical response and will provide key information to develop more personalized and effective treatment strategies.
Insights
Identifying biomarkers for immune checkpoint blockade response is crucial for patient treatment. This review categorizes biomarkers into tumor-intrinsic, immune microenvironmental, host-related, and dynamic factors to predict therapy success.
Area of Science:
- Oncology
- Immunology
- Biomarker Discovery
Background:
- Immune checkpoint blockade (ICB) therapies have shown success in various cancers.
- However, many patients exhibit primary resistance or develop acquired resistance to ICBs.
- Understanding the molecular basis of ICB response is essential for personalized treatment strategies.
Purpose of the Study:
- To review and categorize biomarkers associated with response to immune checkpoint blockade.
- To provide a framework for assessing biomarkers to predict clinical outcomes.
- To enhance the rational and personalized application of ICB therapies.
Main Methods:
- Systematic review and classification of existing biomarkers for ICB activity.
- Categorization into four major groups: tumor-intrinsic, immune microenvironmental, host-related, and dynamic factors.
- Proposed model for assessing baseline and dynamic biomarkers in relation to patient outcomes.
Main Results:
- Identified and classified key biomarkers influencing ICB response.
- Highlighted the importance of integrating diverse biomarker types for accurate prediction.
- Emphasized the role of both baseline and dynamic factors in determining treatment efficacy.
Conclusions:
- Biomarker-driven stratification is critical for optimizing ICB therapy.
- A comprehensive understanding of tumor-immune interactions and dynamics can guide personalized treatment.
- Further research and systematic biomarker assessment will improve patient outcomes in cancer immunotherapy.
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Predicting Molecular Geometry
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
End Point Prediction: Gran Plot
For potentiometric titration, the Gran plot is created by plotting...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...

